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by reporter assay, nuclear accumulation of β-catenin (Western blotting), or
expression of Axin-2 mRNA. Gene expression analysis of chondrocyte mark-
ers including Col2A1, Col1A1, Col10A1, Aggrecan, Sox9, MMP3, MMP13,
ADAMTS5 was performed by quantitative real time PCR.
Results: Wnt3a induced the activation of both the canonical and the
CaMKII-dependent pathways. More importantly, using a systematic strat-
egy of blockade of the different pathways, we have separated the effects
that are directly dependent on the activation of the canonical pathway,
including proliferation, from those that are non-canonical such as disrup-
tion of the chondrocyte phenotype, as evaluated by downregulation of
differentiation markers, and cell survival. Most importantly we have built
up a model in which, through reciprocal inhibition of these two pathways,
either excessive Wnt3a stimulation or blockade equally leads to cartilage
breakdown.
Conclusions: – Wnt3a can activate either the canonical or the CaMKII-
dependent Wnt signaling pathway in adult human articular chondrocytes
– The β-catenin and the CaMKII-dependent Wnt pathways are reciprocally
inhibitory
– The Wnt3a-dependent canonical and non canonical pathway activation
has distinct outcomes
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ALARMINS S100A8 AND S100A9 SKEW CHONDROCYTES TOWARDS A
CARTILAGE BREAKDOWN PHENOTYPE IN HUMAN OSTEOARTHRITIS
R.F. Schelbergen1, P.L. van Lent1, A.B. Blom1, A. Sloetjes1, T. Vogl2,
J. Roth2, W.B. van den Berg1
1Dept. of Rheumatology, Radboud Univ. Med. Ctr., Nijmegen, Netherlands;
2Inst. of Immunology, Univ. of Muenster, Muenster, Germany
Purpose: Alarmins S100A8 and S100A9 are members of the S100 fam-
ily of Ca2+-binding proteins that are associated with inﬂammation and
bone erosion during human rheumatoid arthritis (RA). Recently, we found
that S100A8 and S100A9 are also associated with cartilage degradation
in murine collagenase-induced osteoarthritis (OA). We also showed that
S100A8 and S100A9 stimulate expression and activity of matrix metallopro-
teinases (MMPs) and pro-inﬂammatory cytokines in murine chondrocytes.
We now investigated whether S100A8, S100A9 and/or S100A8/S100A9
complex could also activate human chondrocytes from OA patients and
skew them towards a cartilage breakdown phenotype.
Methods: Cartilage was collected from human OA patients undergoing joint
replacement. Immunostaining was performed on paraﬃn sections of OA
cartilage using antibodies against S100A8 and S100A9 and against VDIPEN
and NITEGE, which are MMP- and A disintegrin and metalloproteinase with
thrombospondin motifs (ADAMTS)-induced cartilage breakdown neoepi-
topes. Chondrocytes were isolated from OA cartilage and stimulated with
recombinant S100A8, S100A9, S100A8/A9 heterodimer and/or interleukin
1 beta (IL-1beta). mRNA levels of MMPs, cytokines and cartilage matrix
molecules were determined with RT-qPCR and protein levels of MMP and
cytokine using Luminex.
Results: Immunostaining on OA cartilage showed that both S100A8 and
S100A9 protein were expressed in and around chondrocytes. Furthermore,
immunostaining of breakdown neoepitopes VDIPEN and NITEGE was found
in the same areas as the S100 proteins.
Stimulation of OA chondrocytes with the monomers S100A8 and S100A9
for 24 hours strongly stimulated cartilage degrading molecules like MMPs
and cytokines. mRNA expression of MMP1, -3, -9 and -13 was upregulated
4-, 4-, 3- and 3-fold respectively. Protein levels of MMP1, -3 and -13
were upregulated 234, 27 and 136% respectively. Moreover, particularly
interleukin 6 (IL-6) levels were strongly upregulated on mRNA level (11-
fold) and protein levels reached 5 ng/ml. The catabolic effect of S100A8
and S100A9 was almost comparable to IL-1beta effects, but there was no
additive effect of S100 with IL-1beta, suggesting independent mechanisms.
Apart from stimulating cartilage degradation, S100A8 and S100A9
monomers also inhibited new formation of cartilage matrix molecules.
mRNA levels of aggrecan and collagen type II were signiﬁcantly decreased
2- to 3-fold, suggesting that these proteins inhibit repair.
In contrast to the monomers, the heterodimer S100A8/A9 neither had effect
on cartilage degradation nor on cartilage matrix production.
Conclusions: S100A8 and S100A9 expression is found in areas with car-
tilage breakdown in OA cartilage. Moreover these proteins inhibit new
formation of matrix molecules and stimulate production of cartilage
degrading molecules thereby skewing chondrocytes towards a cartilage
breakdown phenotype.
S100A8 and/or S100A9 may serve as therapeutic targets for the treatment
of cartilage damage during OA.
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EFFECTS OF TGF-BETA ON OA CHONDROCYTE MITOCHONDRIA
A. Mates, A. Pearsall IV, V. Grishko
Univ. of South Alabama, Mobile, AL
Purpose: TGF- beta is a powerful anabolic factor for chondrocytes and plays
an important role by enhancing cartilage repair. Oxidative stress and mito-
chondrial damage have been found to promote cell death, functional failure
and degeneration. There is a growing body of evidence that mitochondrial
dysfunction is present during the progression of osteoarthritis. The purpose
of the present study was to evaluate whether TGF-beta enhances cartilage
repair through the prevention of mitochondrial DNA damage and dys-
function in human OA chondrocytes subjected to experimentally-induced
oxidative stress.
Methods: Primary OA chondrocytes cultures, generated from cartilage from
patients undergoing total knee replacement, were exposed for 30 min to
reactive oxygen species (ROS) generators xanthine oxidase/hypoxanthine
or peroxynitrite. Some cells were pre-incubated with 5 ng/ml of TGF-beta
for 24 h prior to treatment. In some experiments cells were incubated
for 48 h with IL-1 beta or TNF-alpha alone or in combination with TGF-
beta. Following exposure, cells were immediately lysed for DNA isolation,
protein isolation, ATP analysis, or replenished with normal growth media
and left for recovery and then analyzed. Mitochondrial dysfunction was
assessed in terms of mitochondrial DNA damage (Quantitative Southern
blot analysis), ATP content (Bioluminescence kit), mitochondrial proteins
levels (Western blot). Cell viability and apoptosis were evaluated by ﬂow
cytometry. Additionally, Western blot was applied to perform caspase 9
cleavage assay.
Results: When OA chondrocytes were exposed to ROS generators, mito-
chondrial dysfunction and apoptosis were accumulated as a consequence.
Pretreatment with TGF- beta preserved mitochondrial DNA integrity, ATP
levels, and restored drop in mitochondrial protein levels. Moreover, TGF-
beta enhanced chondrocytes viability and diminished the appearance of
apoptosis. The similar results were obtained for IL-1 beta and TNF-alpha.
Interestingly, TGF-beta did not have effect on nitric oxide levels enhanced
following pro-inﬂammatory cytokine exposure of chondrocytes.
Conclusions: The present results demonstrate for the ﬁrst time the mi-
toprotective properties of TGF-beta and offer additional explanation of
the mechanisms through which TGF-beta enhances cartilage repair. More
studies required evaluating more precisely the observed TGF- beta effects.
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P38 AND MEK/ERK MAP KINASES REGULATE COMMON AND UNIQUE
GENE SETS IN CHONDROCYTES
V. Ulici, L.-A. Stanton, C.G. James, F. Beier
Univ. Of Western Ontario, London, ON, Canada
Purpose: The cartilage growth plate regulates growth of endochondral
bones, and ectopic initiation of growth plate events (e.g. chondrocyte
hypertrophy) in articular chondrocytes contributes to the development of
osteoarthritis. MAPK signaling pathways have been implicated in different
aspects of growth plate development. In this study we focus on two
MAPK pathways: p38 and MEK/ERK. We analyzed the effects of these two
pathways on mouse growth plate chondrocyte gene expression and bone
growth in culture. Some of the speciﬁc roles of the p38 and MEK/ERK
pathways have been already investigated, but no study so far reported on
the effects of their simultaneous inhibition. We hypothesized that these
two signaling pathways have antagonizing roles in different aspects of the
growth plate development and the simultaneous inhibition will result in a
reduction of their speciﬁc effects.
Methods: RNA was isolated from mouse growth plate chondrocytes af-
ter 24 hours of culture in the presence of UO126 (MEK/ERK inhibitor),
SB202190 (p38 inhibitor) or DMSO (control) and hybridized to Affymetrix
MOE 430 2.0 gene chips (n = 3). The data were normalized and analyzed
using GeneSpring GX 7.3.1 and Ingenuity Pathway Analysis (IPA). The
expression of selected genes was conﬁrmed by real-time PCR. In addition,
mouse embryonic tibiae were cultured for 6 days in the presence of DMSO,
SB202190 (SB), UO126 (U) or SB202190+ UO126 (SU). Bone growth was
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measured over the time course and tibiae were embedded, sectioned and
analyzed histologically. Immunohistochemistry for known chondrocyte and
bone markers and selected markers identiﬁed in our microarray analyses
was performed. Other stains such as Safranin O, VonKossa and TRAP were
also performed.
Results: The two MAP Kinases p38 and MEK/ERK are known to have
opposite effects on chondrocyte differentiation: p38 is overall a positive
regulator and MEK/ERK a negative regulator. We focused mostly on genes
down-regulated by the SB and up-regulated by U treatments. 88 probe sets
were both >1.45 down-regulated by SB and up-regulated by U. Among
these genes we conﬁrmed a subset by real-time PCR: Col10a1, Matn3,
Ihh, Papss2, Fgfr3, Sp7 and Alpl. These common genes were also identiﬁed
by IPA analysis in different functional categories such as: “development
of skeleton”, “osteochondrodysplasia”, “osteoarthritis” and “osteoblast dif-
ferentiation”. One interesting hypertrophic chondrocyte/bone marker, Ibsp
was highly down-regulated by SB (5 fold), but unaffected by U. In addition
to the separate effects of the two inhibitors (SB and U) on gene expression,
we also analyzed by real-time PCR the effects of a combined SB and U treat-
ment (SU). For genes such as Ihh, SU treatment brought its expression level
close to DMSO, suggesting that the opposite effects of the two pathways in
chondrocytes were canceled when they were simultaneously inactivated.
This was not the case for all markers; e.g some terminal differentiated
chondrocyte/bone markers such as Tnfrsf11a (RANK) and Tnfsf11 (RANKL)
were down-regulated by both pathways.
In tibia organ culture, bone growth was signiﬁcantly reduced by SB, in-
creased in the presence of U and close to DMSO control in SU treatment.
Upon safranin O staining of tibia sections, we noticed smaller cells in
the proliferative area of SB treated bones that were organized in poorly
deﬁned columns. Both length and width of different growth plate zones
were measured. Hypertrophic zone length was decreased in SB and SU, but
unaffected by U, while the proliferative zone was increased in U only. The
whole growth plate area was decreased in SB and SU and increased in U,
and the width of the hypertrophic zone was increased in U only.
Conclusion: In conclusion, the two MAPK pathways had opposite effects
on speciﬁc steps of the endochondral ossiﬁcation process, and these effects
were canceled when the two pathways were inhibited simultaneously.
However, other processes were mainly affected by one of the two path-
ways (e.g. Ibsp expression) or regulated by both p38 and MEK/ERK in the
same direction (e.g. the expression of Tnfrsf11a and Tnfsf11).
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AGE DEPENDENT VARIATION OF SODIUM CONCENTRATION IN HUMAN
KNEE CARTILAGE MEASURED AT 7T
V.B. Kassey1, G. Ramanathan1, A. Shore1, S.N. Vallespin2, T. Connick1,
A. Singh1, H. Hariharan1, R. Reddy1
1Univ. of Pennsylvania, Philadelphia, PA; 2NHS Fndn. Trust, Chelsea, London,
United Kingdom
Purpose: To determine the age dependent variation of molecular changes
in human knee cartilage via sodium MRI at ultrahigh ﬁelds.
Introduction: Aggrecan along with Type-II collagen forms a major struc-
tural component of cartilage, particularly articular cartilage. Aggrecan (a
large aggregating proteoglycan [PG]) has been shown to undergo predom-
inant change in early OA. While OA is a disease of diverse etiologies
cartilage tissue is primarily affected. The loss of PG is an initiating event
in the OA. By monitoring sodium concentration in tissues via 23Na MRI,
the integrity of the cartilage tissue can be analyzed in vivo, which provides
OA diagnosis and disease evaluation. Before quantifying the OA changes
with any noninvasive method, it is critical to estimate the natural course
of molecular degeneration in cartilage matrix. In the present study, using
sodium MRI at ultrahigh ﬁeld, we investigated the natural, age dependent
molecular changes in the healthy human knee cartilage in vivo.
Methods: All human studies were approved by the Institutional Review
Board. The knees of three healthy young male (20-24 years) and three aged
(43-59 years) male volunteers were imaged on 7T Siemens MRI scanner.
We used a custom built birdcage coil tuned to sodium frequency with
optimal SNR. Sodium MRI was performed using an Ultra short Echo (UTE)
(Siemens medical solutions, Erlangen) 3D radial sequence with a mean
SNR of 24 (TR=75ms, TE = 0.07ms, FOV=16cm, Matrix =128×128×128 and
600 radial spokes for total scan time of 45 sec per image). 16 individual
acquisitions (12 min total acquisition time) were co-added oﬄine to further
improve SNR for more accurate concentration measurements. The same
parameters were maintained in all experiments for all subjects for direct
comparison. For B1 ﬁeld variation and concentration corrections, a phantom
with 250 mM Nacl and 5% agarose was imaged and appropriate calibrations
were computed. The images obtained using UTE sequence have higher SNR
compared to 3D FLASH sequence (approximately by a factor of 20) for
comparable scan time of 12 - 15min.
Results and Discussion: The sodium concentration maps (Fig. 1) show
differences in sodium concentration in human knee cartilage between a
young male volunteer (24 years) and an aged male volunteer (59 years).
The same trend is observed in the other subjects as well. The B1 ﬁeld
variations were found to be ∼10% in the knee and concentration corrections
have been computed for sodium concentration in the human cartilage and
the agarose phantom. The sodium concentration measured in younger
group is in the range of 242mM - 253mM (mean of 247.5 mM) and in
aged group is 209mM - 220 mM (mean of 214.5mM), which shows 15%
variation of sodium concentration in both the age groups. As described in
literature, these sodium maps can be used to calculate the tissue’s ﬁxed
charge density (FCD), which is a map of Aggrecan distribution.
Figure 1. Comparison of sodium concentration in young (24 years) and aged (59 years)
human subjects. (a) Axial, (b) saggital views of a 24 year (young) male volunteer. (c) Axial,
(d) saggital views of a 59 year (aged) male volunteer. (e) Calibration Phantom of 250mM
NaCl and 5% Agarose.
Conclusion: These preliminary results demonstrate that it is feasible to
obtain sodium maps of human knee in-vivo at 7T with reasonable acquisi-
tion times and quantify age dependent molecular changes in knee cartilage
of healthy human subjects. Further work is in progress to quantify age
dependent Aggrecan changes in larger groups of subjects to quantitatively
establish the natural course of degenerative changes in cartilage.
Sponsor: This work was supported by Award Number P41RR002305 from
NCRR and NIHR0145404 from the NIAMS of NIH.
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VALPROIC ACID SUPPRESSES INTERLEUKIN-1β-INDUCED MICROSOMAL
PROSTAGLANDIN E2 SYNTHASE-1 EXPRESSION IN CHONDROCYTES
N. Zayed, F. El Mansouri, N. Chabane, J. Martel-pelletier, J.-P. Pelletier,
H. Fahmi
Montreal Univ., Montreal, QC, Canada
Purpose: Microsomal prostaglandin E2 Synthase (mPGES)-1 catalyzes the
terminal step in the biosynthesis of PGE2. Early growth response factor-1
(Egr-1) is a key transcription factor in the regulation of mPGES-1. In the
present study we examined the effects of valproic acid (VA), a histone
deacetylase (HDAC) inhibitor, on interleukin (IL)-1β-induced mPGES-1-
expression in human chondrocytes
Methods: Chondrocytes were stimulated with IL-1 in the absence or pres-
ence of VA, and the level of mPGES-1 protein and mRNA expression were
evaluated using Western blotting and real-time reverse-transcription poly-
merase chain reaction, respectively. The mPGES-1 promoter activity was
analyzed in transient transfection experiments. Egr-1 recruitment to the
mPGES-1 promoter were evaluated using chromatin immunoprecipitation
(ChIP) assays.
Results: VA dose-dependently suppressed IL-1β-induced mPGES-1 protein
and mRNA expression as well as its promoter activation. Treatment with
VA did not alter IL-1-induced Egr-1 expression, nor its recruitment to the
mPGES-1 promoter, but prevented its transcriptional activity
Conclusions: Our study demonstrates that VA inhibits IL-1-inducedmPGES-
1 expression in chondrocytes. The suppressive effect of VA was not due to
reduced expression or recruitment of Egr-1 to the mPGES-1 promoter.
